Stephen Howard, D.Phil.

Following his education at Oxford University, Stephen Howard has had a long and successful career as an equity analyst. Working for one of the world's largest banks, he heads the global TMT practice, and has consistently topped surveys of financial investors as providing the best equity research. He has also worked for IBM, including at the prestigious T.J. Watson Research Laboratory. Stephen was the founding investor behind the creation of Molecular Templates Inc., a company that is now entering Phase I clinical trials in Non-Hodgkin’s Lymphoma with a an innovative ADC therapy, and was a long-standing board member.